Clinical Trials

A marijuana extract significantly reduced seizures in severely epileptic children, according to a landmark study conducted in part at Lurie Children’s Hospital of Chicago. Supporters said the results greatly improve the chances for the drug, called Epidiolex, to win eventual approval by federal regulators for prescription use to treat Dravet syndrome, a debilitating type of […]

Researchers at the University of Pittsburgh School of Medicine and Arts and Sciences say they have designed a more potent version of the FDA-approved epilepsy drug retigabine. A study published on March 22, 2016 in Molecular Pharmacology compares RL648_81 (RL-81), the experimental agent developed by Pitt researchers, with retigabine, and SF0034, a KCNQ2/3 activator being […]

by

Getty As medical marijuana becomes legal in more states across the country, there’s been a spike in public interest to see whether cannabis can effectively treat mood disorders such as anxiety, depression, and psychosis that are commonly associated with bipolar disorder. Unfortunately, there are conflicts in scientific consensus for both supporting and opposing views of […]

by

Medical Marijuana Inc (OTCMKTS:MJNA) has so far trailed other pot stocks in 2016. However, this could change pretty quick as Medical Marijuana Inc is one of best known names among pot stock enthusiasts. We think this is more likely than not as a new marijuana Green Rush looks to be starting. We’ve been talking about […]

by

Notis Global Inc (OTCMKTS:NGBL) has a new name and a new symbol as it looks to erase the stench that was Medbox Inc. Medbox left investors with large losses as the company went on a wave of dilution and socked it to the average investor. As Notis Global, the company is hoping that it can […]

by

March 14, 2016 Cannabidiol Therapy Reduces Seizure Frequency in Dravet Syndrome Investigators have announced positive results for the first phase 3 clinical trial of GW Pharmaceutical’s cannabidiol therapy Epidiolex in patients with Dravet syndrome. The unpublished results mark a milestone for Epidiolex, which has already received Orphan Drug Designation and Fast Track Designation from the […]

by